Intrexon Corp Reaches New 12-Month Low at $20.10 (XON)
Shares of Intrexon Corp (NYSE:XON) hit a new 52-week low during trading on Friday, Analyst RN reports. The stock traded as low as $20.10 and last traded at $21.08, with a volume of 375,935 shares trading hands. The stock had previously closed at $21.15.
A number of analysts have recently weighed in on XON shares. Analysts at Griffin Securities initiated coverage on shares of Intrexon Corp in a research note to investors on Monday, September 30th. They set a “buy” rating and a $36.00 price target on the stock. Separately, analysts at Barclays Capital initiated coverage on shares of Intrexon Corp in a research note to investors on Tuesday, September 3rd. They set an “equal weight” rating and a $25.00 price target on the stock. Finally, analysts at JPMorgan Chase & Co. initiated coverage on shares of Intrexon Corp in a research note to investors on Tuesday, September 3rd. They set an “overweight” rating on the stock.
Intrexon Corp has a 1-year low of $20.65 and a 1-year high of $31.44. The stock’s 50-day moving average is $23.2 and its 200-day moving average is $23.98. The company’s market cap is $2.118 billion.
Intrexon Corporation is engaged in the business of synthetic biology. Using the Company’s suite of complementary technologies, it design, build and regulate gene programs, or sequences of deoxyribonucleic acid (NYSE:XON) that control cellular function, and cellular systems, or activities that take place within a cell and the interaction of those systems in the greater cellular environment, to enable the development of new and improved products and manufacturing processes across a variety of end markets, including healthcare, food, energy and environmental sciences.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.